CEACAM5 and neoplasm: We also evaluated the levels of the established clinical tumor biomarkers Carcinoembryonic Antigen (CEA) and Cytokeratin Fragment Antigen-21 (CYFRA 21-1) in serum-derived exosomes and corresponding serum samples (Figure 5).